Moreover, TGF-β1 and NCK1-AS1 overexpression increased ESCC cell migration and invasion, while TGF-β inhibitor reduced the effects of NCK1-AS1 overexpression. This evidence concerns the gene NCK1 and esophageal squamous cell carcinoma.